Heart Sector, Hygeia Hospitals Group, HHG, 5, Erithrou Stavrou, Marousi, Athens 15123, Greece.
European Heart Agency, ESC, Brussels, Belgium.
Eur Heart J. 2022 Jan 31;43(4):271-279. doi: 10.1093/eurheartj/ehab874.
This article presents some of the most important developments in the field of digital medicine that have appeared over the last 12 months and are related to cardiovascular medicine. The article consists of three main sections, as follows: (i) artificial intelligence-enabled cardiovascular diagnostic tools, techniques, and methodologies, (ii) big data and prognostic models for cardiovascular risk protection, and (iii) wearable devices in cardiovascular risk assessment, cardiovascular disease prevention, diagnosis, and management. To conclude the article, the authors present a brief further prospective on this new domain, highlighting existing gaps that are specifically related to artificial intelligence technologies, such as explainability, cost-effectiveness, and, of course, the importance of proper regulatory oversight for each clinical implementation.
本文介绍了过去 12 个月中与心血管医学相关的数字医学领域的一些最重要的进展。文章主要分为三个部分:(i)人工智能支持的心血管诊断工具、技术和方法,(ii)大数据和心血管风险保护预后模型,以及(iii)心血管风险评估、心血管疾病预防、诊断和管理的可穿戴设备。在文章的最后,作者对这个新领域进行了简要的前瞻性展望,强调了与人工智能技术相关的一些现有差距,例如可解释性、成本效益,当然,还有每个临床应用的适当监管监督的重要性。